Spyre TherapeuticsSYRE
那斯達克 · USD
71.07
-2.43
(-3.31%)
盤中 06/02 01:05 (UTC+8)
06/02 01:05 (UTC+8)
Spyre TherapeuticsSYRE
71.07
-2.43
(-3.31%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 75,641 | 57,172 | 56,888 | 51,935 | - | - | - | - | 47,774 | - |
研發費用 | 60,411 | 44,638 | 45,247 | 40,145 | 41,623 | 50,482 | 44,744 | 32,636 | 34,928 | 33,682 |
推銷及管理費用 | 15,230 | 12,534 | 11,641 | 11,790 | 11,944 | 10,771 | 10,648 | 11,511 | 12,846 | 14,072 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -45,641 | -57,172 | -56,888 | -41,935 | -53,567 | -61,253 | -55,392 | -44,147 | -47,774 | -45,914 |
其他收入及費用 | 6,636 | -5,358 | 45,705 | 15,218 | 8,779 | 4,958 | -13,618 | 5,310 | 3,949 | -15,426 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -69,005 | -62,530 | -11,183 | -36,717 | -44,788 | -56,295 | -69,010 | -38,837 | -43,825 | -63,180 |
所得稅 | - | - | - | - | -15 | 1 | 18 | - | 32 | - |
稅後純益 | -69,005 | -62,530 | -11,183 | -36,717 | -44,773 | -56,296 | -69,028 | -38,837 | -43,857 | -63,180 |
基本每股稅後盈餘(元) | -0.74 | -0.70 | -0.18 | -0.60 | -0.60 | -0.81 | -1.35 | -0.85 | -0.72 | - |
稀釋每股稅後盈餘(元) | -0.74 | -0.74 | -0.18 | -0.49 | -0.60 | -0.79 | -1.08 | -0.59 | -0.72 | 0.89 |
基本平均股數(千股) | 78548.00 | 75088.00 | 60776.00 | 60696.00 | 60265.00 | 55259.00 | 51252.00 | 45828.00 | 36512.00 | - |
稀釋平均股數(千股) | 78548.00 | 75088.00 | 60776.00 | 60696.00 | 60265.00 | 55259.00 | 51252.00 | 45828.00 | 36512.00 | - |
還原基本每股稅後盈餘(元) | -0.74 | -0.70 | -0.18 | -0.60 | -0.60 | -0.81 | -1.35 | -0.85 | -0.72 | - |
還原稀釋每股稅後盈餘(元) | -0.74 | -0.74 | -0.18 | -0.49 | -0.60 | -0.79 | -1.08 | -0.59 | -0.72 | 0.89 |
還原基本平均股數(千股) | 78,548 | 75,088 | 60,776 | 60,696 | 60,265 | 55,259 | 51,252 | 45,828 | 36,512 | - |
還原稀釋平均股數(千股) | 78,548 | 75,088 | 60,776 | 60,696 | 60,265 | 55,259 | 51,252 | 45,828 | 36,512 | - |
EBITDA(千元) | -71,064 | -64,615 | -12,533 | -38,730 | -47,430 | -58,714 | -72,011 | -42,398 | -46,248 | -64,886 |